Cathepsin B has been shown to degrade type IV collagen at the surface of breast and colorectal cancer cells via a proteolytic cascade involving MMPs and the serine protease urokinase plasminogen activator (uPA) [272,273]. This evidence concerns the gene PLAU and colorectal cancer.